Detection of colistin sensitivity in clinical isolates of Acinetobacter baumannii in Iran

Journal of Research in Medical Sciences

Volumn 19, Issue SPEC. ISSUE, 2014, Pages

  Vakili, Bahareh ^a   Fazeli, Hossein ^b   Shoaei, Parisa ^c   Yaran, Majid ^d   Ataei, Behrooz ^b   Khorvash, Farzin ^c   Khaleghi, Moj ^e  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID BAHONAR UNIVERSITY OF KERMAN   (Iran)

Author keywords

Acinetobacter baumannii; Colistin resistance; Multidrug resistant organism

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; SULTAMICILLIN;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISK DIFFUSION; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; HYDROLYSIS; INTENSIVE CARE UNIT; IRAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE;

EID: 84900338109     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ducel G, Fabry J, Nicolle L, Girard R, Perraud M, Prüss A, et al. Prevention of hospital-acquired infections. Available from: http://www.who.int/emc. [Last accessed on 2013 Dec 11].
2. Arroyo LA, García-Curiel A, Pachón-Ibañez ME, Llanos AC, Ruiz M, Pachón J, et al. Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J Clin Microbiol 2005;43:903-5.
3. Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: Citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 2000;31:101-6.
4. Chien ST, Lin CH, Hsueh JC, Li PL, Hsu CH, Chang SH, et al. Mutation of gyrA and parC in clinical isolates of Acinetobacter baumannii and its relationship with antimicrobial drugs resistance in Taiwan. Ann Microbiol 2009;59:369-72.
5. Ko KS, Suh JY, Kwon KT, Jung SI, Park KH, Kang CI, et al. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J Antimicrob Chemother 2007;60:1163-7.
6. Owen RJ, Li J, Nation RL, Spelman D. In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates. J Antimicrob Chemother 2007;59:473-7.
7. Dent LL, Marshall DR, Pratap S, Hulette RB. Multidrug resistant Acinetobacter baumannii: A descriptive study in a city hospital. BMC Infect Dis 2010;10:196.
8. Mohammadtaheri Z, Pourpaki M, Mohammadi F, Namdar R, Masjedi MR. Surveillance of antimicrobial susceptibility among bacterial isolates from intensive care unit patients of a tertiary-care university hospital in Iran:2006-2009. Chemotherapy 2010;56:478-84.
9. Soroush S, Haghi-Ashtiani MT, Taheri-Kalani M, Emaneini M, Aligholi M, Sadeghifard N, et al. Antimicrobial resistance of nosocomial strain of Acinetobacter baumannii in Children's Medical Center of Tehran: A 6-year prospective study. Acta Med Iran 2010;48:178-84.
10. Jain R, Danziger LH. Multidrug-resistant Acinetobacter infections: An emerging challenge to clinicians. Ann Pharmacother 2004;38:1449-59.
11. Sinirtaş M, Akalin H, Gedikoǧlu S. Investigation of colistin sensitivity via three diff erent methods in Acinetobacter baumannii isolates with multiple antibiotic resistance. Int J Infect Dis 2009;13:e217-20.
12. Cockerill FR. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Twenty Second International Supplement M100-S22. USA: Clinical and Laboratory Standards Institute; 2012.
13. Lockhart SR, Abramson MA, Beekmann SE, Gallagher G, Riedel S, Diekema DJ, et al. Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol 2007;45:3352-9.
14. Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I, et al. Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care 2003;7:R78-83.
15. The European Committee on Antimicrobial Suceptibility Testing (EUCAST). Clinical MIC breakpoints. Available from: http://www.srga.org/eucastwt/MICTAB/MICmiscellaneous.html. [Last accessed on 2013 Jan 7].
16. Arroyo LA, Mateos I, González V, Aznar J. In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group. Antimicrob Agents Chemother 2009;53:1295-6.
17. Cai Y, Chai D, Wang R, Liang B, Bai N. Colistin resistance of Acinetobacter baumannii: Clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother 2012;67:1607-15.
18. Ahmed SH, Fekry Abdelwahab S, Hasanen AM, Mohammed DS. Multidrug resistant Egyptian isolates of Acinetobacter baumannii. J Am Sci 2011;7:1013-9.
19. Mastoraki A, Douka E, Kriaras I, Stravopodis G, Saroglou G, Geroulanos S. Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units. Eur J Cardiothorac Surg 2008;33:1086-90.
20. Mulin B, Rouget C, Clément C, Bailly P, Julliot MC, Viel JF, et al. Association of private isolation rooms with ventilator-associated Acinetobacter baumanii pneumonia in a surgical intensive-care unit. Infect Control Hosp Epidemiol 1997;18:499-503.